Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity
Mohamed Sabry, Mariam A. Ghaly, Azza R. Maarouf, et al.
European Journal of Medicinal Chemistry (2022) Vol. 241, pp. 114661-114661
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Recent advances on biologically active coumarin-based hybrid compounds
Metin Yıldırım, Samet Poyraz, Mehmet Erşatır
Medicinal Chemistry Research (2023) Vol. 32, Iss. 4, pp. 617-642
Closed Access | Times Cited: 35
A comprehensive review on thiazole based conjugates as anti-cancer agents
Rupali Rana, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136194-136194
Closed Access | Times Cited: 21
A fluorescence switch-off nanosensor for sensitive determination of the antiandrogen drug flutamide in pharmaceutical and environmental samples. Analytical method greenness, blueness, and whiteness assessment
Walaa Nabil Abd‐AlGhafar, Rasha Abo Shabana, Rania El‐Shaheny, et al.
Microchemical Journal (2024) Vol. 204, pp. 111078-111078
Closed Access | Times Cited: 9
Efficient synthesis and molecular docking analysis of quinazoline and azole hybrid derivatives as promising agents for anti-cancer and anti-tuberculosis activities
Gourav Kumar, Parveen Kumar, Akta Soni, et al.
Journal of Molecular Structure (2024) Vol. 1310, pp. 138289-138289
Closed Access | Times Cited: 7
Design, synthesis, and in silico studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38α MAPK kinase inhibitory effects
Aisha A. Alsfouk, Ismail M. M. Othman, Manal M. Anwar, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 1407-1424
Open Access
Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR/HER2 target inhibition
Mostafa E. Salem, Esraa M. Mahrous, Eman A. Ragab, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Recent pharmacological insights about imidazole hybrids: a comprehensive review
Samet Poyraz, Metin Yıldırım, Mehmet Erşatır
Medicinal Chemistry Research (2024) Vol. 33, Iss. 6, pp. 839-868
Closed Access | Times Cited: 6
New thiazole derivatives linked to pyridine, fused pyridine, pyrimidine and thiazolopyrimidine scaffolds with potential dual anticancer and antimicrobial activities: Design, synthesis and docking simulation
Zahra M. Al-Amshany, Eman S. Nossier
Journal of Molecular Structure (2024) Vol. 1316, pp. 138973-138973
Closed Access | Times Cited: 6
Novel thiazole-based cyanoacrylamide derivatives: DNA cleavage, DNA/BSA binding properties and their anticancer behaviour against colon and breast cancer cells
Karim Barakat, Mohamed A. Ragheb, Marwa H. Soliman, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Exploring 1,2,3-triazole-Schiff’s base hybrids as innovative EGFR inhibitors for the treatment of breast cancer: In vitro and in silico study
Nareman A. Nawareg, Asmaa S. A. Yassen, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108106-108106
Closed Access
Synthesis, characterization, anticancer potential and mechanisms of cytotoxic activity of phosphoramide derivatives; experimental and theoretical study
Khodayar Gholivand, Azam Barzegari, Marjan Ghorbani-Anarkooli, et al.
Inorganic Chemistry Communications (2025), pp. 113917-113917
Closed Access
Design, Synthesis and Molecular Docking of New Thieno[2,3‑d]Pyrimidin‐4‐One Derivatives as Dual EGFR and FGFR Inhibitors
Sara Sultan, Samar S. Tawfik, Khalid B. Selim, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
Evaluation of Novel Pyridine-Based Compounds Integrating Bioactive Amide and Hydrazide Groups as a Potential Fungicide Agent
Shuo Wang, Zhanfang Chen, S.-H. Li, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Design, synthesis and molecular modeling of new Pyrazolyl-Benzimidazolone hybrids targeting breast Cancer
Mohamed Adardour, Al‐Hassan M. Mustafa, Mehdi Oubahmane, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108269-108269
Closed Access
Discovery of new thiazolidin-4-one and thiazole nucleus incorporation sulfaguanidine scaffold as new class of antimicrobial agents: Design, synthesis, in silico ADMET, and docking simulation
Ola A. Abu Ali, Ahmed Ragab, Yousry A. Ammar, et al.
Journal of Molecular Structure (2025), pp. 141879-141879
Closed Access
Synthesis, modeling, and biological studies of new thiazole-pyrazole analogues as anticancer agents
Gadeer R.S. Ashour, Ahmad Fawzi Qarah, Abdulmajeed F. Alrefaei, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 4, pp. 101669-101669
Open Access | Times Cited: 13
Identification of new 5-(2,6-dichlorophenyl)-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-7-carboxylic acids as p38α MAPK inhibitors: Design, synthesis, antitumor evaluation, molecular docking and in silico studies
Marwa H. El‐Wakil, Hadeel A. El-Dershaby, Rasha A Ghazallah, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107226-107226
Closed Access | Times Cited: 2
Evaluation of antioxidant activity in different Egyptian barley cultivars: an in vitro and in silico study
Omneya Eid, Shahira M. Ezzat, Wafaa M. Elkady, et al.
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Synthesis, molecular modeling simulations and anticancer activity of some new Imidazo[2,1-b]thiazole analogues as EGFR/HER2 and DHFR inhibitors
Esraa A. Moharram, Selwan M. El‐Sayed, Hazem A. Ghabbour, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107538-107538
Closed Access | Times Cited: 2
New 2-alkoxycyanopyridine derivatives as inhibitors of EGFR, HER2, and DHFR: Synthesis, anticancer evaluation, and molecular modeling studies
Samia S. Hawas, Selwan M. El‐Sayed, Perihan A. Elzahhar, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106874-106874
Closed Access | Times Cited: 6
Novel Glu-based pyrazolo[3,4-d]pyrimidine analogues: design, synthesis and biological evaluation as DHFR and TS dual inhibitors
Mater H. Mahnashi, Mohammed Merae Alshahrani, Amer Al Ali, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
Design and Synthesis of New 4-(3,4,5-Trimethoxyphenyl)Thiazole–Pyrimidine Derivatives as Potential Antiproliferative Agents
Ashraf K. El‐Damasy, Heewon Jin, Mohamed Sabry, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1076-1076
Open Access | Times Cited: 5
Appraisal and synthesis of novel indole-thiazole derivatives as epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors against resistance mutation for lung cancer treatment
Shailee V. Tiwari, Dattatraya N. Pansare, Deepak K. Lokwani, et al.
Results in Chemistry (2024) Vol. 11, pp. 101760-101760
Open Access | Times Cited: 1
Multi-targeted anti-Alzheimer's agents: Synthesis, biological evaluation, and molecular modeling study of some pyrazolopyridine hybrids
Omnia M. Waly, Selwan M. El‐Sayed, Mariam A. Ghaly, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115880-115880
Closed Access | Times Cited: 4
Synthesis of novel series of heterocyclic compounds having two azoles against Methicillin-sensitive Staphylococcus aureus
Abdulwahab Alamri, Ahmed Alafnan, Bader Huwaimel, et al.
Journal of Molecular Structure (2022) Vol. 1277, pp. 134863-134863
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top